Literature DB >> 18521630

Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas.

Davut Pehlivan1, Esra Gunduz, Mehmet Gunduz, Hitoshi Nagatsuka, Levent Bekir Beder, Beyhan Cengiz, Rosario S Rivera, Kunihiro Fukushima, Sukru Palanduz, Sukru Ozturk, Noboru Yamanaka, Kenji Shimizu.   

Abstract

PURPOSE AND METHODS: Loss of heterozygosity (LOH) in a chromosomal location indicates the presence of an inactivated tumor suppressor gene (TSG). Inactivation of TSG has a functional role in the tumorigenesis of head and neck squamous cell carcinoma (HNSCC). Based on the recent evidences of a putative TSG on chromosome 14, we examined LOH on chromosome 14q using eight polymorphic microsatellite markers in 50 cases of HNSCCs.
RESULTS: Three regions were detected to have a high LOH rate which included 14q21.2-22.3 (42.5%), 14q31 (55%), and 14q32.1 (37%). The correlation between LOH and clinicopathological findings was investigated through statistical analyses. A strong correlation was observed between the highest LOH marker and the overall and disease-free survival.
CONCLUSIONS: The results suggest that the distal part of chromosome 14 may host a TSG that may lead to the development and/or progression of HNSCCs. Several genes such as CHES1, BMP4, SAV, and PNN have arisen as candidate tumor suppressors in the region.

Entities:  

Mesh:

Year:  2008        PMID: 18521630     DOI: 10.1007/s00432-008-0423-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  Microsatellite allelotyping of chinese nasopharyngeal carcinomas.

Authors:  M L Lung; C V Choi; H Kong; P W Yuen; D Kwong; J Sham; W I Wei
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

2.  Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma.

Authors:  Wensheng Yan; Lanying Song; Weidong Wei; Ang Li; Jihong Liu; Yan Fang
Journal:  Tumour Biol       Date:  2005-10-26

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Loss of heterozygosity of 14q32 in colorectal carcinoma.

Authors:  T Bando; Y Kato; Y Ihara; F Yamagishi; K Tsukada; M Isobe
Journal:  Cancer Genet Cytogenet       Date:  1999-06

5.  Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.

Authors:  M Gunduz; M Ouchida; K Fukushima; H Hanafusa; T Etani; S Nishioka; K Nishizaki; K Shimizu
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

6.  CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor.

Authors:  Kenneth L Scott; Sharon E Plon
Journal:  Gene       Date:  2005-10-10       Impact factor: 3.688

7.  Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells.

Authors:  Tagvor G Nishanian; Jung-Sik Kim; Aaron Foxworth; Todd Waldman
Journal:  Cancer Biol Ther       Date:  2004-07-10       Impact factor: 4.742

Review 8.  Genetic approaches to the study of the molecular basis of human cancer.

Authors:  C M Croce
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

9.  Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer.

Authors:  D T Ransom; T C Barnett; J Bot; B de Boer; C Metcalf; J A Davidson; G R Turbett
Journal:  Head Neck       Date:  1998-08       Impact factor: 3.147

10.  Loss of Sin3/Rpd3 histone deacetylase restores the DNA damage response in checkpoint-deficient strains of Saccharomyces cerevisiae.

Authors:  Kenneth L Scott; Sharon E Plon
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more
  11 in total

1.  CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Authors:  Natalia G Starostina; Jennifer M Simpliciano; Michael A McGuirk; Edward T Kipreos
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

2.  SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin β1 signaling pathway in hepatocellular carcinoma.

Authors:  Ying Jing; Deshui Jia; Chun-Ming Wong; Irene Oi-Lin Ng; Zhenfeng Zhang; Li Liu; Qifeng Wang; Fangyu Zhao; Jinjun Li; Ming Yao; Xingzhong Wu; Xianghuo He
Journal:  Mol Oncol       Date:  2013-12-18       Impact factor: 6.603

3.  Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.

Authors:  Arthur Kwok Leung Cheung; Hong Lok Lung; Josephine Mun Yee Ko; Yue Cheng; Eric J Stanbridge; Eugene R Zabarovsky; John M Nicholls; Daniel Chua; Sai Wah Tsao; Xin-Yuan Guan; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma.

Authors:  Jarosław Markowski; Tomasz Tyszkiewicz; Michał Jarzab; Małgorzata Oczko-Wojciechowska; Tatiana Gierek; Małgorzata Witkowska; Jarosław Paluch; Małgorzata Kowalska; Zbigniew Wygoda; Dariusz Lange; Barbara Jarzab
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-16       Impact factor: 2.503

5.  DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.

Authors:  Jiangzhou Peng; Baishen Chen; Zhuojian Shen; Heran Deng; Degang Liu; Xuan Xie; Xiangfeng Gan; Xia Xu; Zhiquan Huang; Ju Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.

Authors:  Rupert L Mayer; Josef D Schwarzmeier; Marlene C Gerner; Andrea Bileck; Johanna C Mader; Samuel M Meier-Menches; Samuel M Gerner; Klaus G Schmetterer; Tobias Pukrop; Albrecht Reichle; Astrid Slany; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2017-12-01       Impact factor: 5.911

7.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

8.  A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.

Authors:  Xu Guo; Xi Ma; Jiaze An; Yukui Shang; Qichao Huang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis.

Authors:  Geneviève Huot; Mathieu Vernier; Véronique Bourdeau; Laurent Doucet; Emmanuelle Saint-Germain; Marie-France Gaumont-Leclerc; Alejandro Moro; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2014-01-08       Impact factor: 4.138

10.  Knockdown of SET Domain, Bifurcated 1 suppresses head and neck cancer cell viability and wound-healing ability in vitro.

Authors:  Sibel Özdaş
Journal:  Turk J Biol       Date:  2019-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.